Key Details As 3rd Circ. Ponders FCA's Fate, $1.6B J&J Fine

Third Circuit judges Wednesday explored divergent views of the False Claims Act’s constitutionality and a record fraud verdict against Johnson & Johnson, expressing little eagerness to gut the FCA’s whistleblower mechanism, and voicing uncertainty about evidence and jury instructions underpinning the drug promotion punishment.

Continue reading →